Mablink Bioscience
Latest round
- Series A
Last raised
- Sep 2022
Total raised
- $35M
Investors
- 9
About Mablink Bioscience
S. operates as a biotechnology company that focuses on developing drug therapies for cancer. The company was founded by CEO Jean-Guillaume Lafay and CSO Warren Viricel. Mablink Bioscience provides PSARlink™ is the company’s patented ADC platform that focuses on hydrophilic drug-linker and improvement of pharmacological properties.
Who invested in Mablink Bioscience
9 investors across 2 rounds
See all investors in Mablink Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mablink Bioscience
Who invested in Mablink Bioscience?
Mablink Bioscience has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mablink Bioscience raised?
Mablink Bioscience has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Mablink Bioscience last raise money?
Mablink Bioscience's most recent round on record is a Series A, in Sep 2022.
What does Mablink Bioscience do?
Mablink Bioscience is a biotechnology company.
Where is Mablink Bioscience headquartered?
Mablink Bioscience is headquartered in Lyon, France.
Which VCs invest in companies like Mablink Bioscience?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Mablink Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Mablink Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.